As illustrated by two recent cases, there has been an uptick in Government enforcement action related to pharmaceutical manufacturer donations to patient assistance funds designed to assist patients with copay obligations. Earlier this month, the U.S. District Court for the District of Massachusetts denied Regeneron Pharmaceuticals’ motion to dismiss a lawsuit in which the... READ MORE
Recent Government Actions Against Pharma Manufacturers Highlight Risks with Donations to Patient Assistance Funds
Posted on December 22, 2020 in False Claims Act Defense
Published by: Hall Render
